The Food and Drug Administration (FDA) last night issued an emergency use authorization (EUA) for the Moderna COVID-19 vaccine, bringing a second vaccine to the United States' battle against the pandemic and making it the first country to have two authorized vaccines that come with clear and compelling efficacy data.The formal announcement follows the Dec 17 recommendation of the FDA independent expert panel, the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
And it allows shipping to begin for use in people ages 18 and older. Federal officials have said they expect to ship 5.9 million Moderna doses to states next week.In a statement, FDA Commissioner Stephen Hahn, MD, said, "With the availability of two vaccines now